 |
Welcome to Genelux - intro
Genelux, Genelux Corporation, GL-ONC1, GLV-1h68, San Diego, California, Bernried,
Germany, Redlands, California, Genelux GmbH, Research and development, R&D, Product development, Oncolytic virotherapy, Oncolytic viral therapy, Live vector therapy,
Live vector-mediated therapy, Immunotherapy, Gene therapy, Biotech, biotechnology, Oncology, Clinical oncology, Virology, Molecular biology, Microbiology, Genetic engineering,
Gene regulation, Gene induction, Bioluminescence, Imaging, Cancer research, Cancer drug, Cancer product, Cancer therapy, Cancer treatment, Cancer clinical trials,
Clinical trials Phase I, Clinical trials Phase I/II, Preclinical studies, Preclinical research, Disease targets, Breast cancer, breast tumor, breast metastases,
Lung cancer, lung tumor, lung metastases , Mesothelioma, Pancreatic cancer, pancreatic tumor, pancreatic metastases, Liver cancer, lung tumor, lung metastases,
Ovarian cancer, Ovarian tumor, Ovarian metastases, Colon cancer, Colon tumor, Colon metastases, Prostate cancer, prostate tumor, prostate metastases, Metastatic cancer,
Metastatic tumor, Metastatic metastases, Anaplastic thyroid carcinoma, Anaplastic thyroid cancer, Anaplastic thyroid tumor, Anaplastic thyroid metastases, Solid tumors,
Solid metastases, Inflammatory diseases, Mutant virus, genetically-engineered virus, genetically-altered virus, genetically-modified virus, attenuated virus, Bacteria, Microbe,
Vaccinia virus, Smallpox vaccine, E. coli Nissle 1917, Renilla luciferase, Green fluorescent protein, GFP, Red fluorescent protein, RFP, Ruc-GFP, RFP-CBG99, Sea pansy, Jellyfish,
Fusion protein, Fusion transgene, Fusion payload, Light-emitting protein, glowing protein, Marker gene, Insertion capacity, carrying capacity, Cancer therapy, tumor therapy,
metastases therapy, Cancer inhibition, tumor inhibition, metastases inhibition, Cancer illumination, tumor illumination, metastases illumination, Cancer visualization,
tumor visualization, metastases visualization, Cancer colonization, tumor colonization, metastases colonization, cancer accumulation, tumor accumulation, metastases accumulation,
Cancer regression, tumor regression, metastases regression, Cancer elimination, tumor elimination, metastases elimination, Cancer eradication, tumor eradication, metastases eradication,
Cancer destruction, tumor destruction, metastases destruction, Cancer localization, tumor localization, metastases localization, Cancer detection, tumor detection, metastases detection,
Cancer imaging, tumor imaging, metastases imaging, Cancer diagnosis, tumor diagnosis, metastases diagnosis, Cancer monitoring, tumor monitoring, metastases monitoring, Cancer staging,
tumor staging, metastases staging, Anti-tumor activity, Anti-tumor effects, Combination therapy, Combination treatment, Low light imaging, Real-time imaging, optical imaging,
Mechanism of action, Viral oncolysis, Micro-pharmaceutical factory, Pharmaceutical factory, Systemic intravenous i.v. delivery administration injection,
Cytoplasmic viral replication accumulation amplification, Cancer tumor metastases selectivity selective preferential, Safe haven, Non-invasive detection imaging,
Innate adaptive immune antigen response stimulation activation, Intraoperative imaging, Immune re-building, Aladar A. Szalay, Ronald Roy A. Simus, Joachim-Friedrich Kapp
Albert Roeder, John Thomas, Caroline Staib, Shahrokh Shabahang, Tony Yu, Yong A. Yu, Qian Zhang, Nanhai Chen, Jochen Stritzker, Louis Z. Stromberg, James Chang,
Charles Crocker, Wolfram Brune, Yuman Fong, Francesco Marincola, E. Peter Greenberg, Stan Kaye, Christoph Hubert Huber, Philip S. Schein, Reinhard Wilhelm Von Roemeling,
GL-ONC1 virotherapy viral therapy 3D animation, Transforming cancer from a terminal disease to a manageable condition, Illuminating life
Genelux.com ~
Site Info
Whois
Trace Route
RBL Check
|
Site Info
